271 related articles for article (PubMed ID: 17032933)
1. Economic burden of deep-vein thrombosis, pulmonary embolism, and post-thrombotic syndrome.
MacDougall DA; Feliu AL; Boccuzzi SJ; Lin J
Am J Health Syst Pharm; 2006 Oct; 63(20 Suppl 6):S5-15. PubMed ID: 17032933
[TBL] [Abstract][Full Text] [Related]
2. Direct medical costs of venous thromboembolism and subsequent hospital readmission rates: an administrative claims analysis from 30 managed care organizations.
Spyropoulos AC; Lin J
J Manag Care Pharm; 2007; 13(6):475-86. PubMed ID: 17672809
[TBL] [Abstract][Full Text] [Related]
3. Inpatient resource use and cost burden of deep vein thrombosis and pulmonary embolism in the United States.
LaMori JC; Shoheiber O; Mody SH; Bookhart BK
Clin Ther; 2015 Jan; 37(1):62-70. PubMed ID: 25524389
[TBL] [Abstract][Full Text] [Related]
4. All-cause and potentially disease-related health care costs associated with venous thromboembolism in commercial, Medicare, and Medicaid beneficiaries.
Lefebvre P; Laliberté F; Nutescu EA; Duh MS; LaMori J; Bookhart BK; Olson WH; Dea K; Schein J; Kaatz S
J Manag Care Pharm; 2012 Jun; 18(5):363-74. PubMed ID: 22663169
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal evaluation of health plan cost per venous thromboembolism or bleed event in patients with a prior venous thromboembolism event during hospitalization.
Bullano MF; Willey V; Hauch O; Wygant G; Spyropoulos AC; Hoffman L
J Manag Care Pharm; 2005 Oct; 11(8):663-73. PubMed ID: 16194130
[TBL] [Abstract][Full Text] [Related]
6. Recurrent hospitalization and healthcare resource use among patients with deep vein thrombosis and pulmonary embolism: findings from a multi-payer analysis.
Lang K; Patel AA; Munsell M; Bookhart BK; Mody SH; Schein JR; Menzin J
J Thromb Thrombolysis; 2015 May; 39(4):434-42. PubMed ID: 25079971
[TBL] [Abstract][Full Text] [Related]
7. Post-thrombotic syndrome after primary event of deep venous thrombosis 10 to 20 years ago.
Ziegler S; Schillinger M; Maca TH; Minar E
Thromb Res; 2001 Jan; 101(2):23-33. PubMed ID: 11342203
[TBL] [Abstract][Full Text] [Related]
8. Hospital charges associated with "never events": comparison of anterior cervical discectomy and fusion, posterior lumbar interbody fusion, and lumbar laminectomy to total joint arthroplasty.
Daniels AH; Kawaguchi S; Contag AG; Rastegar F; Waagmeester G; Anderson PA; Arthur M; Hart RA
J Neurosurg Spine; 2016 Aug; 25(2):165-9. PubMed ID: 26989978
[TBL] [Abstract][Full Text] [Related]
9. Incremental health care resource utilization and economic burden of venous thromboembolism recurrence from a U.S. payer perspective.
Lin J; Lingohr-Smith M; Kwong WJ
J Manag Care Pharm; 2014 Feb; 20(2):174-86. PubMed ID: 24456319
[TBL] [Abstract][Full Text] [Related]
10. Incidence of hospital readmission in patients diagnosed with DVT and PE: clinical burden of recurrent events.
Nutescu EA; Crivera C; Schein JR; Bookhart BK
Int J Clin Pract; 2015 Mar; 69(3):321-7. PubMed ID: 25395271
[TBL] [Abstract][Full Text] [Related]
11. Daily hospitalization costs in patients with deep vein thrombosis or pulmonary embolism treated with anticoagulant therapy.
Dasta JF; Pilon D; Mody SH; Lopatto J; Laliberté F; Germain G; Bookhart BK; Lefebvre P; Nutescu EA
Thromb Res; 2015 Feb; 135(2):303-10. PubMed ID: 25555319
[TBL] [Abstract][Full Text] [Related]
12. Economic burden of long-term complications of deep vein thrombosis after total hip replacement surgery in the United States.
Caprini JA; Botteman MF; Stephens JM; Nadipelli V; Ewing MM; Brandt S; Pashos CL; Cohen AT
Value Health; 2003; 6(1):59-74. PubMed ID: 12535239
[TBL] [Abstract][Full Text] [Related]
13. Cost-Effectiveness Analysis of Rivaroxaban for Treatment of Deep Vein Thrombosis and Pulmonary Embolism in Greece.
Gourzoulidis G; Kourlaba G; Kakisis J; Matsagkas M; Giannakoulas G; Gourgoulianis KI; Vassilakopoulos T; Maniadakis N
Clin Drug Investig; 2017 Sep; 37(9):833-844. PubMed ID: 28608312
[TBL] [Abstract][Full Text] [Related]
14. Incidence of post-thrombotic syndrome in patients with previous pulmonary embolism. A retrospective cohort study.
Bova C; Rossi V; Ricchio R; Greco A; Bloise A; Daniele F; Greco F; Noto A
Thromb Haemost; 2004 Nov; 92(5):993-6. PubMed ID: 15543325
[TBL] [Abstract][Full Text] [Related]
15. Thrombosis density ratio can predict the occurrence of pulmonary embolism and post-thrombotic syndrome in lower-extremity deep vein thrombosis patients.
Yao MM; Lin TT; Shi X; Chen MG; Wu JX; Zhao YP; Lin BS
Clin Hemorheol Microcirc; 2024; 86(4):395-405. PubMed ID: 38073380
[TBL] [Abstract][Full Text] [Related]
16. Use of managed care claims data in the risk assessment of venous thromboembolism in outpatients.
Russell MW; Taylor DC; Cummins G; Huse DM
Am J Manag Care; 2002 Jan; 8(1 Suppl):S3-9. PubMed ID: 11822347
[TBL] [Abstract][Full Text] [Related]
17. Inpatient and outpatient occurrence of deep vein thrombosis and pulmonary embolism and thromboprophylaxis following selected at-risk surgeries.
Amin AN; Lin J; Thompson S; Wiederkehr D
Ann Pharmacother; 2011 Sep; 45(9):1045-52. PubMed ID: 21862717
[TBL] [Abstract][Full Text] [Related]
18. Carbon monoxide poisoning and risk of deep vein thrombosis and pulmonary embolism: a nationwide retrospective cohort study.
Chung WS; Lin CL; Kao CH
J Epidemiol Community Health; 2015 Jun; 69(6):557-62. PubMed ID: 25614638
[TBL] [Abstract][Full Text] [Related]
19. Economic burden and cost determinants of deep vein thrombosis during 2 years following diagnosis: a prospective evaluation.
Guanella R; Ducruet T; Johri M; Miron MJ; Roussin A; Desmarais S; Joyal F; Kassis J; Solymoss S; Ginsberg JS; Lamping DL; Shrier I; Kahn SR
J Thromb Haemost; 2011 Dec; 9(12):2397-405. PubMed ID: 21951970
[TBL] [Abstract][Full Text] [Related]
20. A cost analysis of the treatment of patients with post-thrombotic syndrome in Brazil.
Ramacciotti E; Gomes M; de Aguiar ET; Caiafa JS; de Moura LK; Araújo GR; Truzzi A; Dietrich-Neto F;
Thromb Res; 2006; 118(6):699-704. PubMed ID: 16417913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
